US Patent 10053454 Carbazole compounds useful as bromodomain inhibitors
Patent 10053454 was granted and assigned to Bristol-Myers Squibb on August, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+228 characters)
Article
Patent abstract
The present invention is directed to carbazole compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using the compositions in the treatment of various disorders.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Infobox
Patent Inventor Names
Ashok Vinayak Purandare0
Ashvinikumar V. Gavai0
Christopher P. Mussari0
Daniel O'Malley0
David R. Tortolani0
Dharmpal S. Dodd0
John S. Tokarski0
Lalgudi S. Harikrishnan0
Michael A. Poss0
Muthoni G. Kamau0
Tram N. Huynh0
Wayne Vaccaro0
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100534540
Date of Patent
August 21, 2018
0Patent Application Number
147702300
Date Filed
February 27, 2014
0Patent Citations Received
Patent Primary Examiner
Edits on 23 Feb, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10053454 Carbazole compounds useful as bromodomain inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10053454
Date of patent
August 21, 2018
Patent application number
14770230
Date Filed
February 27, 2014
Patent primary examiner
Find more entities like US Patent 10053454 Carbazole compounds useful as bromodomain inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
